Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Clinical trial NCT02189343 · COMPLETED
Trial details
- NCT number
- NCT02189343
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2018-04-18
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.